bind therapeutics
AstraZeneca signs $200m nanomedicine deal
April 23, 2013Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine
AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
